[Retracted] A Potential Prognostic Biomarker for Glioma: Aldo-Keto Reductase Family 1 Member B1

Figure 1

AKR1B1 expression between cancer and normal tissues in glioma patients. (a) AKR1B1 expression levels in glioma and normal tissues. (b) ROC analysis of AKR1B1 showed promising discrimination power between tumor and normal tissues.

(a)

(b)